Search bioRxivSearch

bioRxiv · 10.1101/363382

Combining citizen science and deep learning to amplify expertise in neuroimaging

Abstract

Research in many fields has become increasingly reliant on large and complex datasets. \"Big Data\" holds untold promise to rapidly advance science by tackling new questions that cannot be answered with smaller datasets. While powerful, research with Big Data poses unique challenges, as many standard lab protocols rely on experts examining each one of the samples. This is not feasible for large-scale datasets because manual approaches are time-consuming and hence difficult to scale. Meanwhile, automated approaches lack the accuracy of examination by highly trained scientists and this may introduce major errors, sources of noise, and unforeseen biases into these large and complex datasets. Our proposed solution is to 1) start with a small, expertly labelled dataset, 2) amplify labels through web-based tools that engage citizen scientists, and 3) train machine learning on amplified labels to emulate expert decision making. As a proof of concept, we developed a system to quality control a large dataset of three-dimensional magnetic resonance images (MRI) of human brains. An initial dataset of 200 brain images labeled by experts were amplified by citizen scientists to label 722 brains, with over 80,000 ratings done through a simple web interface. A deep learning algorithm was then trained to predict data quality, based on a combination of the citizen scientist labels that accounts for differences in the quality of classification by different citizen scientists. In an ROC analysis (on left out test data), the deep learning network performed as well as a state-of-the-art, specialized algorithm (MRIQC) for quality control of T1-weighted images, each with an area under the curve of 0.99. Finally, as a specific practical application of the method, we explore how brain image quality relates to the replicability of a well established relationship between brain volume and age over development. Combining citizen science and deep learning can generalize and scale expert decision making; this is particularly important in emerging disciplines where specialized, automated tools do not already exist.

Source connections

Explore related subjects

Keep this discovery

BibTeXRIS

Keshavan, A., Yeatman, J., Rokem, A.. 2018-07-06. Combining citizen science and deep learning to amplify expertise in neuroimaging. https://doi.org/10.1101/363382

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience